Global PD-L1 Biomarker Testing Market Insights and Forecast to 2028

Report ID: 1241211 | Published Date: Jan 2025 | No. of Page: 114 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 PD-L1 (22C3)
        1.2.3 PD-L1(28-8)
        1.2.4 PD-L1 (SP142)
        1.2.5 PD-L1 (SP263)
        1.2.6 Other
    1.3 Market by Application
        1.3.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Diagnostic Center
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global PD-L1 Biomarker Testing Market Perspective (2017-2028)
    2.2 PD-L1 Biomarker Testing Growth Trends by Region
        2.2.1 PD-L1 Biomarker Testing Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 PD-L1 Biomarker Testing Historic Market Size by Region (2017-2022)
        2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Region (2023-2028)
    2.3 PD-L1 Biomarker Testing Market Dynamics
        2.3.1 PD-L1 Biomarker Testing Industry Trends
        2.3.2 PD-L1 Biomarker Testing Market Drivers
        2.3.3 PD-L1 Biomarker Testing Market Challenges
        2.3.4 PD-L1 Biomarker Testing Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top PD-L1 Biomarker Testing Players by Revenue
        3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2017-2022)
        3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2017-2022)
    3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue
    3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio
        3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2021
    3.5 PD-L1 Biomarker Testing Key Players Head office and Area Served
    3.6 Key Players PD-L1 Biomarker Testing Product Solution and Service
    3.7 Date of Enter into PD-L1 Biomarker Testing Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 PD-L1 Biomarker Testing Breakdown Data by Type
    4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2017-2022)
    4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2023-2028)
5 PD-L1 Biomarker Testing Breakdown Data by Application
    5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2017-2022)
    5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America PD-L1 Biomarker Testing Market Size (2017-2028)
    6.2 North America PD-L1 Biomarker Testing Market Size by Type
        6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2017-2022)
        6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2023-2028)
        6.2.3 North America PD-L1 Biomarker Testing Market Share by Type (2017-2028)
    6.3 North America PD-L1 Biomarker Testing Market Size by Application
        6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2017-2022)
        6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2023-2028)
        6.3.3 North America PD-L1 Biomarker Testing Market Share by Application (2017-2028)
    6.4 North America PD-L1 Biomarker Testing Market Size by Country
        6.4.1 North America PD-L1 Biomarker Testing Market Size by Country (2017-2022)
        6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe PD-L1 Biomarker Testing Market Size (2017-2028)
    7.2 Europe PD-L1 Biomarker Testing Market Size by Type
        7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022)
        7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2023-2028)
        7.2.3 Europe PD-L1 Biomarker Testing Market Share by Type (2017-2028)
    7.3 Europe PD-L1 Biomarker Testing Market Size by Application
        7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022)
        7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2023-2028)
        7.3.3 Europe PD-L1 Biomarker Testing Market Share by Application (2017-2028)
    7.4 Europe PD-L1 Biomarker Testing Market Size by Country
        7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country (2017-2022)
        7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific PD-L1 Biomarker Testing Market Size (2017-2028)
    8.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type
        8.2.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific PD-L1 Biomarker Testing Market Share by Type (2017-2028)
    8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application
        8.3.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific PD-L1 Biomarker Testing Market Share by Application (2017-2028)
    8.4 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region
        8.4.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America PD-L1 Biomarker Testing Market Size (2017-2028)
    9.2 Latin America PD-L1 Biomarker Testing Market Size by Type
        9.2.1 Latin America PD-L1 Biomarker Testing Market Size by Type (2017-2022)
        9.2.2 Latin America PD-L1 Biomarker Testing Market Size by Type (2023-2028)
        9.2.3 Latin America PD-L1 Biomarker Testing Market Share by Type (2017-2028)
    9.3 Latin America PD-L1 Biomarker Testing Market Size by Application
        9.3.1 Latin America PD-L1 Biomarker Testing Market Size by Application (2017-2022)
        9.3.2 Latin America PD-L1 Biomarker Testing Market Size by Application (2023-2028)
        9.3.3 Latin America PD-L1 Biomarker Testing Market Share by Application (2017-2028)
    9.4 Latin America PD-L1 Biomarker Testing Market Size by Country
        9.4.1 Latin America PD-L1 Biomarker Testing Market Size by Country (2017-2022)
        9.4.2 Latin America PD-L1 Biomarker Testing Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa PD-L1 Biomarker Testing Market Size (2017-2028)
    10.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type
        10.2.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa PD-L1 Biomarker Testing Market Share by Type (2017-2028)
    10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application
        10.3.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa PD-L1 Biomarker Testing Market Share by Application (2017-2028)
    10.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country
        10.4.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Agilent Technologies
        11.1.1 Agilent Technologies Company Details
        11.1.2 Agilent Technologies Business Overview
        11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
        11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.1.5 Agilent Technologies Recent Developments
    11.2 Roche
        11.2.1 Roche Company Details
        11.2.2 Roche Business Overview
        11.2.3 Roche PD-L1 Biomarker Testing Introduction
        11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.2.5 Roche Recent Developments
    11.3 Merck
        11.3.1 Merck Company Details
        11.3.2 Merck Business Overview
        11.3.3 Merck PD-L1 Biomarker Testing Introduction
        11.3.4 Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.3.5 Merck Recent Developments
    11.4 Bristol-Myers Squibb
        11.4.1 Bristol-Myers Squibb Company Details
        11.4.2 Bristol-Myers Squibb Business Overview
        11.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction
        11.4.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.4.5 Bristol-Myers Squibb Recent Developments
    11.5 AstraZeneca
        11.5.1 AstraZeneca Company Details
        11.5.2 AstraZeneca Business Overview
        11.5.3 AstraZeneca PD-L1 Biomarker Testing Introduction
        11.5.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.5.5 AstraZeneca Recent Developments
    11.6 Ono Pharmaceutical
        11.6.1 Ono Pharmaceutical Company Details
        11.6.2 Ono Pharmaceutical Business Overview
        11.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Introduction
        11.6.4 Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.6.5 Ono Pharmaceutical Recent Developments
    11.7 Regeneron
        11.7.1 Regeneron Company Details
        11.7.2 Regeneron Business Overview
        11.7.3 Regeneron PD-L1 Biomarker Testing Introduction
        11.7.4 Regeneron Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.7.5 Regeneron Recent Developments
    11.8 Innovent
        11.8.1 Innovent Company Details
        11.8.2 Innovent Business Overview
        11.8.3 Innovent PD-L1 Biomarker Testing Introduction
        11.8.4 Innovent Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.8.5 Innovent Recent Developments
    11.9 Hengrui Medicine
        11.9.1 Hengrui Medicine Company Details
        11.9.2 Hengrui Medicine Business Overview
        11.9.3 Hengrui Medicine PD-L1 Biomarker Testing Introduction
        11.9.4 Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.9.5 Hengrui Medicine Recent Developments
    11.10 Junshi Biosciences
        11.10.1 Junshi Biosciences Company Details
        11.10.2 Junshi Biosciences Business Overview
        11.10.3 Junshi Biosciences PD-L1 Biomarker Testing Introduction
        11.10.4 Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2017-2022)
        11.10.5 Junshi Biosciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of PD-L1 (22C3)
    Table 3. Key Players of PD-L1(28-8)
    Table 4. Key Players of PD-L1 (SP142)
    Table 5. Key Players of PD-L1 (SP263)
    Table 6. Key Players of Other
    Table 7. Global PD-L1 Biomarker Testing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global PD-L1 Biomarker Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global PD-L1 Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global PD-L1 Biomarker Testing Market Share by Region (2017-2022)
    Table 11. Global PD-L1 Biomarker Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global PD-L1 Biomarker Testing Market Share by Region (2023-2028)
    Table 13. PD-L1 Biomarker Testing Market Trends
    Table 14. PD-L1 Biomarker Testing Market Drivers
    Table 15. PD-L1 Biomarker Testing Market Challenges
    Table 16. PD-L1 Biomarker Testing Market Restraints
    Table 17. Global PD-L1 Biomarker Testing Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global PD-L1 Biomarker Testing Revenue Share by Players (2017-2022)
    Table 19. Global Top PD-L1 Biomarker Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2021)
    Table 20. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players PD-L1 Biomarker Testing Product Solution and Service
    Table 24. Date of Enter into PD-L1 Biomarker Testing Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2017-2022)
    Table 28. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2023-2028)
    Table 30. Global PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global PD-L1 Biomarker Testing Revenue Share by Application (2017-2022)
    Table 32. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global PD-L1 Biomarker Testing Revenue Share by Application (2023-2028)
    Table 34. North America PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific PD-L1 Biomarker Testing Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa PD-L1 Biomarker Testing Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa PD-L1 Biomarker Testing Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa PD-L1 Biomarker Testing Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa PD-L1 Biomarker Testing Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa PD-L1 Biomarker Testing Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa PD-L1 Biomarker Testing Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Agilent Technologies Company Details
    Table 65. Agilent Technologies Business Overview
    Table 66. Agilent Technologies PD-L1 Biomarker Testing Product
    Table 67. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 68. Agilent Technologies Recent Developments
    Table 69. Roche Company Details
    Table 70. Roche Business Overview
    Table 71. Roche PD-L1 Biomarker Testing Product
    Table 72. Roche Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 73. Roche Recent Developments
    Table 74. Merck Company Details
    Table 75. Merck Business Overview
    Table 76. Merck PD-L1 Biomarker Testing Product
    Table 77. Merck Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 78. Merck Recent Developments
    Table 79. Bristol-Myers Squibb Company Details
    Table 80. Bristol-Myers Squibb Business Overview
    Table 81. Bristol-Myers Squibb PD-L1 Biomarker Testing Product
    Table 82. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 83. Bristol-Myers Squibb Recent Developments
    Table 84. AstraZeneca Company Details
    Table 85. AstraZeneca Business Overview
    Table 86. AstraZeneca PD-L1 Biomarker Testing Product
    Table 87. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 88. AstraZeneca Recent Developments
    Table 89. Ono Pharmaceutical Company Details
    Table 90. Ono Pharmaceutical Business Overview
    Table 91. Ono Pharmaceutical PD-L1 Biomarker Testing Product
    Table 92. Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 93. Ono Pharmaceutical Recent Developments
    Table 94. Regeneron Company Details
    Table 95. Regeneron Business Overview
    Table 96. Regeneron PD-L1 Biomarker Testing Product
    Table 97. Regeneron Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 98. Regeneron Recent Developments
    Table 99. Innovent Company Details
    Table 100. Innovent Business Overview
    Table 101. Innovent PD-L1 Biomarker Testing Product
    Table 102. Innovent Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 103. Innovent Recent Developments
    Table 104. Hengrui Medicine Company Details
    Table 105. Hengrui Medicine Business Overview
    Table 106. Hengrui Medicine PD-L1 Biomarker Testing Product
    Table 107. Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 108. Hengrui Medicine Recent Developments
    Table 109. Junshi Biosciences Company Details
    Table 110. Junshi Biosciences Business Overview
    Table 111. Junshi Biosciences PD-L1 Biomarker Testing Product
    Table 112. Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2017-2022) & (US$ Million)
    Table 113. Junshi Biosciences Recent Developments
    Table 114. Research Programs/Design for This Report
    Table 115. Key Data Information from Secondary Sources
    Table 116. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global PD-L1 Biomarker Testing Market Share by Type: 2021 VS 2028
    Figure 2. PD-L1 (22C3) Features
    Figure 3. PD-L1(28-8) Features
    Figure 4. PD-L1 (SP142) Features
    Figure 5. PD-L1 (SP263) Features
    Figure 6. Other Features
    Figure 7. Global PD-L1 Biomarker Testing Market Share by Application: 2021 VS 2028
    Figure 8. Hospital Case Studies
    Figure 9. Diagnostic Center Case Studies
    Figure 10. Others Case Studies
    Figure 11. PD-L1 Biomarker Testing Report Years Considered
    Figure 12. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global PD-L1 Biomarker Testing Market Share by Region: 2021 VS 2028
    Figure 15. Global PD-L1 Biomarker Testing Market Share by Players in 2021
    Figure 16. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2021
    Figure 18. North America PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 20. North America PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 21. North America PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 22. United States PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 26. Europe PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 27. Europe PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 28. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific PD-L1 Biomarker Testing Market Size Share by Region (2017-2028)
    Figure 38. China PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Latin America PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 48. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa PD-L1 Biomarker Testing Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa PD-L1 Biomarker Testing Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa PD-L1 Biomarker Testing Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa PD-L1 Biomarker Testing Market Size Share by Country (2017-2028)
    Figure 54. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE PD-L1 Biomarker Testing Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 60. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 61. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 62. Ono Pharmaceutical Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 63. Regeneron Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 64. Innovent Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 65. Hengrui Medicine Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 66. Junshi Biosciences Revenue Growth Rate in PD-L1 Biomarker Testing Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
Frequently Asked Questions
PD-L1 Biomarker Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
PD-L1 Biomarker Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
PD-L1 Biomarker Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

EAA Copolymer

EAA Copolymer market is segmented by Type and by Application. Players, stakeholders, and other pa ... Read More